Corporate Council on Africa's

Health Working Group


Presents



First Malaria Vaccine in Africa:

Partnership Opportunities to Expand Vaccine Access


With guest speakers:

 

Ashley Birkett

Director, PATH's Malaria Vaccine Initiative

 

Dr. Mary Hamel

Lead, Malaria Vaccine Implementation Programme, WHO

 

Dr. Kwaku Poku (KP) Asante

Director, Kintampo Health Research Centre

 

Speaker (TBC)

GSK Vaccines



Tuesday, November 19, 2019

3:00 pm – 4:30 pm


Corporate Council on Africa

1100 17th St N.W., Suite 1200

Washington, DC 20036


Each year, malaria claims the lives of more than 400,000 people, with one child dying from malaria every two minutes. Today, the world's first malaria vaccine is reaching thousands of children in Africa through a vaccine pilot program in selected areas of Ghana, Kenya and Malawi. This is the first and only vaccine that has demonstrated it can significantly reduce malaria and life-threatening severe malaria in young African children.

 

Join CCA for a roundtable discussion including representatives from GSK, PATH, and WHO. Speakers will share the latest updates on the Malaria Vaccine Implementation Programme (MVIP) and the partnership opportunities for private sector companies interested in supporting the implementation program and expanding access to the vaccine beyond the MVIP.



For more information, please contact:

Morayor Essieh on messieh@corporatecouncilonafrica.com.



Location

Corporate Council on Africa
1100 17th Street, NW, Suite 1200
Washington, DC

Closest Metros: Farragut West and Farragut North

See route

Sponsors and Partners